The Pure-Play's Guide To Branding Biosimilars

Our CEO, Peter Moesta, recently spoke with Anna Rose Welch  from Biosimilar Development regarding Adello's rebranding effort. In the interview, Peter talks about Adello's singular focus on #biosimilars and the importance of building a company culture from the bottom up.

About Adello Biologics, LLC

Adello is a privately held, U.S.-based biotechnology company that leads with science to accelerate development and drive manufacturing efficiency. The company’s aim is to provide high-quality, affordable biosimilars to patients worldwide. Headquartered in Piscataway, NJ and driven by a team of highly skilled industry veterans, Adello is advancing a strategic pipeline of proteins and complex monoclonal antibodies with lead candidates in oncology and immunology. For more information, visit

Learn more about biosimilars:

For additional information:
Adello Biologics, LLC
Source: Adello Biologics, LLC

Join Our Mailing List